Clinical Trials
5 trialsNCT02465060 2026-06-03
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00787267 2016-06-30
TOP0801
Duke University
Phase 2 Terminated
NCT00570401 2016-01-22
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01491633 2014-07-15
Dasatinib in Advanced Squamous Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00858403 2014-01-15
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated